More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...
A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.
Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...
At least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...
A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results